Hjem › Amyloidose › Massachusetts › Boston
Kliniske studier for Amyloidose i Boston, MA
11 studier for Amyloidose søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RekruttererObservasjonsstudie
- Research Site, Boston
- Research Site, Boston
- Research Site, Boston
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
RekruttererFase 3
- Clinical Trial Site, Boston
- Clinical Trial Site, Boston
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
RekruttererFase 3
- Clinical Trial Site, Boston
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
RekruttererObservasjonsstudie
- Clinical Trial Site, Boston
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Rekrutterer
- Massachusetts General Hospital, Boston
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RekruttererFase 3
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
RekruttererFase 3
- Brigham and Women's Hospital, Boston
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
RekruttererFase 1/2
- Research Site, Boston
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
RekruttererFase 1/2
- Boston Medical Center /ID# 255066, Boston
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RekruttererFase 3
- Brigham and Women's Hospital, Boston
- Boston University School of Medicine, Boston
Molecular Imaging of Primary Amyloid Cardiomyopathy
Rekrutterer
- Brigham and Womens' Hospital, Boston
Amyloidose-studier i andre byer
- Rochester, MN10 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Philadelphia, PA7 studier
- Houston, TX6 studier
- Baltimore, MD6 studier
- Durham, NC6 studier
- Portland, OR6 studier
- St. Louis, MO6 studier
- San Diego, CA5 studier
- Cleveland, OH5 studier
- Chicago, IL5 studier
Andre studier i Boston
- Brystkreft111 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)86 studier
- Kolorektal kreft63 studier
- Metastatisk kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.